Logo image of PTHS

PELTHOS THERAPEUTICS INC (PTHS) Stock Analyst Earnings Estimates

NYSEARCA:PTHS - NYSE Arca - US1711262048 - Common Stock - Currency: USD

19.04  -0.89 (-4.47%)

After market: 18.01 -1.03 (-5.41%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
PTHS revenue by date.PTHS revenue by date.
199.9KN/A
-100.00%
N/AN/AN/A5.749M27.094M
371.28%
63.019M
132.59%
EBITDA
YoY % growth
PTHS ebitda by date.PTHS ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PTHS ebit by date.PTHS ebit by date.
-1.354MN/A
38.03%
N/A
-176.31%
N/A
-196.02%
-7.036M
-2.53%
-12.087M
-71.79%
-15.606M
-29.11%
N/A
Operating Margin
PTHS operating margin by date.PTHS operating margin by date.
-677.29%N/AN/AN/AN/A-210.25%-57.60%N/A
EPS
YoY % growth
PTHS eps by date.PTHS eps by date.
N/AN/AN/AN/A-1.33-1.12
15.38%
-1.07
4.55%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-6.39
-1,919.35%
-0.44
-51.24%
-0.26
92.03%
Revenue
Q2Q % growth
N/A1.917MN/A
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
-4.131M
-129.59%
-3.804M
-85.69%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-3.20 -2.14-1.06-49.39%
Q3 2024
Q2Q % growth
-0.29 -0.23-0.06-23.61%
PTHS Yearly EPS VS EstimatesPTHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
PTHS Yearly Revenue VS EstimatesPTHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2025 2026 2027 20M 40M 60M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1919.35% N/A 0% N/A
RevenueN/A N/A N/A N/A